THURSDAY, Feb. 20, 2020 (HealthDay News) — Love to cross-country ski? Well, all those days spent striding across the snow-covered wilderness may do more than keep you in great physical shape. Swedish researchers report that very fit long-distance skiers were about 30% less likely to develop Parkinson’s disease during theirContinue Reading

WEDNESDAY, Feb. 12, 2020 (HealthDay News) — Researchers who have pinpointed an antibody linked to life-threatening autoimmune disorders in children say their discovery could lead to faster diagnosis and treatment of these patients. The investigators identified the myelin oligodendrocyte glycoprotein (MOG) antibody in their study of 535 children with centralContinue Reading

THURSDAY, Jan. 16, 2020 (HealthDay News) — For people with the mysterious chronic pain condition fibromyalgia, researchers say nerve stimulation may offer some relief. In a recent study, use of TENS — transcutaneous electrical nerve stimulation — during movement or activity was shown to significantly reduce pain associated with fibromyalgiaContinue Reading

(HealthDay News) — Lupus is an autoimmune disease in which your body attacks its own organs and tissues. Inflammation from lupus can affect your joints, skin, kidneys, blood cells, brain, heart and lungs, says Mayo Clinic. Mayo mentions these common signs of lupus: Fatigue and fever. Joint pain, stiffness andContinue Reading

THURSDAY, Dec. 19, 2019 (HealthDay News) — People suffering from the autoimmune disease lupus might soon have a new drug to turn to, a clinical trial suggests. Anifrolumab is a lab-created antibody that blocks type 1 interferon, a biochemical that activates an immune response in humans, explained lead researcher EricContinue Reading